- Home
- BYD vs BPMC Comparison
BYD vs BPMC Comparison
Compare BYD & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYD
- BPMC
- Stock Information
- Founded
- BYD 1973
- BPMC 2008
- Country
- BYD United States
- BPMC United States
- Employees
- BYD N/A
- BPMC N/A
- Industry
- BYD Hotels/Resorts
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- BYD Consumer Discretionary
- BPMC Health Care
- Exchange
- BYD Nasdaq
- BPMC Nasdaq
- Market Cap
- BYD 5.7B
- BPMC 5.8B
- IPO Year
- BYD 1993
- BPMC 2015
- Fundamental
- Price
- BYD $64.68
- BPMC $84.69
- Analyst Decision
- BYD Buy
- BPMC Buy
- Analyst Count
- BYD 16
- BPMC 22
- Target Price
- BYD $94.33
- BPMC $124.48
- AVG Volume (30 Days)
- BYD 1.0M
- BPMC 1.2M
- Earning Date
- BYD 04-24-2025
- BPMC 05-01-2025
- Dividend Yield
- BYD 1.11%
- BPMC N/A
- EPS Growth
- BYD 1.16
- BPMC N/A
- EPS
- BYD 6.19
- BPMC N/A
- Revenue
- BYD $3,930,194,000.00
- BPMC $508,824,000.00
- Revenue This Year
- BYD $1.95
- BPMC $45.70
- Revenue Next Year
- BYD $2.65
- BPMC $31.83
- P/E Ratio
- BYD $10.45
- BPMC N/A
- Revenue Growth
- BYD 5.13
- BPMC 104.04
- 52 Week Low
- BYD $49.34
- BPMC $73.04
- 52 Week High
- BYD $80.50
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- BYD 44.41
- BPMC 47.15
- Support Level
- BYD $63.71
- BPMC $78.66
- Resistance Level
- BYD $65.58
- BPMC $83.50
- Average True Range (ATR)
- BYD 3.00
- BPMC 5.00
- MACD
- BYD 0.35
- BPMC 0.20
- Stochastic Oscillator
- BYD 56.89
- BPMC 67.15
About BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.